My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 220

    1.

    Building an immune-mediated coagulopathy consensus: early recognition and evaluation to enhance post-surgical patient safety.

    Ness P, Creer M, Rodgers GM, Naoum JJ, Renkens K, Voils SA, Alexander WA; the Recognition, Evaluation and Treatment of Acquired Coagulopathy Consensus (RETACC) Panel.

    Patient Saf Surg. 2009 May 22;3(1):8.PMID: 19463180 [PubMed - as supplied by publisher]Related articlesFree article

    2.

    Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin.

    Ortel TL, Mercer MC, Thames EH, Moore KD, Lawson JH.

    Ann Surg. 2001 Jan;233(1):88-96.PMID: 11141230 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    A review of three stand-alone topical thrombins for surgical hemostasis.

    Cheng CM, Meyer-Massetti C, Kayser SR.

    Clin Ther. 2009 Jan;31(1):32-41. Review.PMID: 19243705 [PubMed - indexed for MEDLINE]Related articles

    4.

    A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins.

    Ofosu FA, Crean S, Reynolds MW.

    Clin Ther. 2009 Apr;31(4):679-91. Review.PMID: 19446142 [PubMed - indexed for MEDLINE]Related articles

    5.

    Immune-mediated coagulopathy: a case report.

    Naoum JJ.

    Pharmacotherapy. 2009 Jul;29(7 Pt 2):13S-7S.PMID: 19558280 [PubMed - indexed for MEDLINE]Related articles

    6.

    Thrombin products: economic impact of immune-mediated coagulopathies and practical formulary considerations.

    Voils SA.

    Pharmacotherapy. 2009 Jul;29(7 Pt 2):18S-22S.PMID: 19558281 [PubMed - indexed for MEDLINE]Related articles

    7.

    The role of fibrin sealants in hemostasis.

    Mankad PS, Codispoti M.

    Am J Surg. 2001 Aug;182(2 Suppl):21S-28S. Review.PMID: 11566473 [PubMed - indexed for MEDLINE]Related articles

    8.

    Massive transfusion and coagulopathy: pathophysiology and implications for clinical management.

    Hardy JF, de Moerloose P, Samama CM; Members of the Groupe d'Intérêt en Hémostase Périopératoire.

    Can J Anaesth. 2006 Jun;53(6 Suppl):S40-58.PMID: 16766790 [PubMed]Related articles

    9.

    Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure.

    Streiff MB, Ness PM.

    Transfusion. 2002 Jan;42(1):18-26. Review.PMID: 11896308 [PubMed - indexed for MEDLINE]Related articles

    10.

    The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.

    Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, Clegg AJ.

    Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. Review.PMID: 19726018 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Massive transfusion and coagulopathy: pathophysiology and implications for clinical management.

    Hardy JF, De Moerloose P, Samama M; Groupe d'intérêt en Hémostase Périopératoire.

    Can J Anaesth. 2004 Apr;51(4):293-310. Review.PMID: 15064258 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Drawing up guidelines for the attendance of physical health of patients with severe mental illness]

    Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL, Azorin JM; avec le soutien institutionnel du laboratoire Lilly.

    Encephale. 2009 Sep;35(4):330-9. Epub 2009 Jul 9. French. PMID: 19748369 [PubMed - indexed for MEDLINE]Related articles

    13.

    Clinical use of topical thrombin as a surgical hemostat.

    Lew WK, Weaver FA.

    Biologics. 2008 Dec;2(4):593-9.PMID: 19707440 [PubMed - in process]Related articlesFree article

    14.

    Neurological complications associated with the treatment of patients with congenital cardiac disease: consensus definitions from the Multi-Societal Database Committee for Pediatric and Congenital Heart Disease.

    Bird GL, Jeffries HE, Licht DJ, Wernovsky G, Weinberg PM, Pizarro C, Stellin G.

    Cardiol Young. 2008 Dec;18 Suppl 2:234-9. Review.PMID: 19063797 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Topical thrombins: benefits and risks.

    Lomax C, Traub O.

    Pharmacotherapy. 2009 Jul;29(7 Pt 2):8S-12S.PMID: 19558279 [PubMed - indexed for MEDLINE]Related articles

    17.

    Coagulopathy: its pathophysiology and treatment in the injured patient.

    Tieu BH, Holcomb JB, Schreiber MA.

    World J Surg. 2007 May;31(5):1055-64. Review.PMID: 17426904 [PubMed - indexed for MEDLINE]Related articles

    18.

    The pathogenesis and management of disseminated intravascular coagulation.

    Saba HI, Morelli GA.

    Clin Adv Hematol Oncol. 2006 Dec;4(12):919-26.PMID: 17235277 [PubMed - indexed for MEDLINE]Related articles

    19.

    Acquired factor V deficiency associated with exposure to bovine thrombin in a burn patient.

    Foster KN, Kim H, Potter K, Matthews MR, Pressman M, Caruso DM.

    J Burn Care Res. 2010 Mar-Apr;31(2):353-60.PMID: 20182366 [PubMed - in process]Related articles

    20.

    Management of massive operative blood loss.

    Kozek-Langenecker S.

    Minerva Anestesiol. 2007 Jul-Aug;73(7-8):401-15. Epub 2007 Mar 27. Review.PMID: 17380100 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk